ONE-WAYOngoing theme · still written in the latest filings
R&D Modality Strategy Centered on Small-Molecule Drugs
The policy is to place small-molecule drugs at the center of research and development, while expanding small-molecule modalities and introducing new modalities.
Companies5How many companies write about this.
Threads5One company can carry more than one thread here.